Systematic Investment Strategy Research
Develop a systematic investment hypothesis into a research specification that can withstand independent review.
What needs to stand up to scrutiny?
An attractive historical equity curve does not establish a reliable investment strategy. The central question is whether an economic or statistical hypothesis survives realistic data timing, sensitivity, trading costs and adverse market conditions.
Problems we can examine.
Every engagement requires an agreed use case, available inputs and reviewable acceptance criteria.
Establish point-in-time datasets, observation timestamps, revision handling and reproducible transformations.
Examine realistic portfolio formation, transaction costs, liquidity, capacity and turnover.
Test parameter stability, regimes, benchmarks and the circumstances in which a signal should be rejected.
A clear sequence of evidence.
The activities below describe potential scope rather than completed work or guaranteed outcomes.
Define the question
Set market universe, investment horizon, decision timestamp, benchmark and rejection criteria before modelling.
Research the evidence
Document data provenance and identify possible leakage, survivorship bias and model-selection effects.
Stress the signal
Compare alternative specifications across market conditions with cost and implementation assumptions made explicit.
Prepare an independent handoff
Deliver traceable signal logic and evidence that a separate analyst can review without relying on research-team conclusions.
Evidence you can inspect.
Outputs depend on the defined mandate. They are not representations of historical client performance, live signals or a regulated financial service.
- Research hypothesis and test protocol
- Point-in-time data and timestamp contract
- Signal definition, benchmarks and reproducible experiments
- Sensitivity, transaction-cost, capacity and failure-condition documentation
- Strategy Research Package (SRP) when included in scope
Who this may suit: Quantitative funds, asset managers, investment offices and financial technology teams investigating or revisiting systematic research ideas.
Before defining a mandate.
Does research imply that a strategy has been validated?
No. Hypothesis development and independent validation are distinct activities. A research result is not represented as approved for trading.
Can you work with our existing dataset?
Potentially, subject to data rights, provenance, timing quality, confidentiality and an agreed scope.
Do you provide guaranteed alpha?
No. Research can reject a hypothesis, and simulations do not guarantee future or realised returns.
These are examples of potential quantitative research, validation or engineering work. No performance, regulatory approval, customer engagement or live financial product is implied. Availability is assessed individually and any permitted delivery requires the appropriate agreements and authorisations.
Start with your model, strategy or analytical question.
Describe the objective, instruments, available data, timing assumptions and constraints. We can discuss an appropriate evidence-led scope.